134
Participants
Start Date
October 31, 2011
Primary Completion Date
March 31, 2015
Study Completion Date
December 31, 2015
MultiStem
single infusion 1-2 days following ischemic stroke
Placebo
single infusion 1-2 days following ischemic stroke
University of Pittsburgh Medical Center Health System, Pittsburgh
Hospital for the University of Pennsylvania, Philadelphia
Palmetto Health Richland, Columbia
Georgia Regents University, Augusta
Florida Hospital Orlando, Orlando
University of Miami, Miami
Chattanooga Center for Neurologic Research, Chattanooga
University of Mississippi Medical Center, Jackson
University of Louisville, Louisville
University of Kentucky Medical Center, Lexington
Case Western Reserve University School of Medicine, Cleveland
MetroHealth Medical Center, Cleveland
Cleveland Clinic, Cleveland
Summa Health System, Akron
University of Cincinnati, Cincinnati
Henry Ford Health System, Detroit
Northwestern University, Chicago
Methodist Hospital Research Institute, Houston
The University of Texas Health Science Center, Houston
University of Utah, Salt Lake City
UCLA Medical Center, Los Angeles
Stanford University, Stanford
Oregon Health Sciences University, Portland
Boston University, Boston
University of Nebraska Medical Center, Omaha
The Pennsylvania State University, Hershey
University of Glasgow - Western Infirmary, Glasgow
University of Glasgow - Southern General Hospital, Glasgow
St. Georges Healthcare NHS Trust, London
University College London Hospitals - Thames Stroke Research Network, London
The Newcastle upon Tyne Hospitals, NHS Foundation Trust, Newcastle upon Tyne
University Hospital of North Staffordshire, Stoke-on-Trent
Lead Sponsor
Collaborators (1)
Medpace, Inc.
INDUSTRY
Healios K.K.
INDUSTRY